- More than 474,000 people globally have leukemia, and acute leukemia is the most aggressive type.
- In a new clinical trial, of the 60 people with certain types of acute leukemia who took a new drug called revumenib, 30% experienced complete remission of the disease.
- Researchers are now hoping to carry out phase 2 trials and further studies to confirm these benefits.
As of 2020, more than 474,000 people around the world have leukemia — a cancer of the blood.
Of the two main types of leukemia,
Read the full article here